Literature DB >> 25896711

Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity.

Olumuyiwa N Adedeji1, Oluseye O Bolaji2, Catherine O Falade1, Odusoga A Osonuga3, Olusegun G Ademowo4.   

Abstract

Artemisinin-based combination therapies (ACTs) have been adopted by most African countries, including Nigeria, as first-line treatments for uncomplicated falciparum malaria. Fixed-dose combinations of these ACTs, amodiaquine-artesunate (FDC AQAS) and artemether-lumefantrine (AL), were introduced in Nigeria to improve compliance and achieve positive outcomes of malaria treatment. In order to achieve clinical success with AQAS, we developed and validated a simple and sensitive high-performance liquid chromatography (HPLC) method with UV detection for determination of amodiaquine (AQ) and desethylamodiaquine (DAQ) in plasma using liquid-liquid extraction of the drugs with diethyl ether following protein precipitation with acetonitrile. Chromatographic separation was achieved using an Agilent Zorbax C18 column and a mobile phase consisting of distilled water-methanol (80:20 [vol/vol]) with 2% (vol/vol) triethylamine, pH 2.2, at a flow rate of 1 ml/min. Calibration curves in spiked plasma were linear from 100 to 1,000 ng/ml (r > 0.99) for both AQ and DAQ. The limit of detection was 1 ng (sample size, 20 μl). The intra- and interday coefficients of variation at 150, 300, and 900 ng/ml ranged from 1.3 to 4.8%, and the biases were between 6.4 and 9.5%. The mean extraction recoveries of AQ and DAQ were 80.0% and 68.9%, respectively. The results for the pharmacokinetic parameters of DAQ following oral administration of FDC AQAS (612/200 mg) for 3 days in female and male patients with uncomplicated falciparum malaria showed that the maximum plasma concentrations (C max) (740 ± 197 versus 767 ± 185 ng/ml), areas under the plasma concentration-time curve (AUC) (185,080 ± 20,813 versus 184,940 ± 16,370 h · ng/ml), and elimination half-life values (T 1/2) (212 ± 1.14 versus 214 ± 0.84 h) were similar (P > 0.05).
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896711      PMCID: PMC4538482          DOI: 10.1128/AAC.04957-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Comparison of the in-vitro activity of amodiaquine and its main metabolite, monodesethyl-amodiaquine, in Plasmodium falciparum.

Authors:  Ulrich Gerstner; Somsak Prajakwong; Gerhard Wiedermann; Jeeraphat Sirichaisinthop; Gunther Wernsdorfer; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2003       Impact factor: 1.704

2.  High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples.

Authors:  O M S Minzi; M Rais; J O Svensson; L L Gustafsson; O Ericsson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-01-15       Impact factor: 3.205

3.  Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro.

Authors:  S T Mariga; J P Gil; C Sisowath; W H Wernsdorfer; A Björkman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate-amodiaquine drug combination.

Authors:  Choon-Sheen Lai; N K Nair; A Muniandy; S M Mansor; P L Olliaro; V Navaratnam
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-25       Impact factor: 3.205

5.  Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper.

Authors:  E N Gitau; S N Muchohi; B R Ogutu; I M Githiga; G O Kokwaro
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-01-05       Impact factor: 3.205

6.  Liquid chromatographic determination of amodiaquine in human plasma.

Authors:  Virendra K Dua; N C Gupta; V P Sharma; S K Subbarao
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-04-25       Impact factor: 3.205

Review 7.  Antimalarial dosing regimens and drug resistance.

Authors:  Karen I Barnes; William M Watkins; Nicholas J White
Journal:  Trends Parasitol       Date:  2008-02-11

8.  Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination.

Authors:  Muhammad Ntale; Celestino Obua; Jackson Mukonzo; Margarita Mahindi; Lars L Gustafsson; Olof Beck; Jasper W Ogwal-Okeng
Journal:  Malar J       Date:  2009-03-30       Impact factor: 2.979

9.  Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers.

Authors:  Visweswaran Navaratnam; Surash Ramanathan; Mohd Suhaimi Ab Wahab; Gan Siew Hua; Sharif Mahsufi Mansor; Jean-René Kiechel; Michel Vaillant; Walter R J Taylor; Piero Olliaro
Journal:  Eur J Clin Pharmacol       Date:  2009-04-30       Impact factor: 2.953

10.  Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.

Authors:  Catherine Orrell; Francesca Little; Peter Smith; Peter Folb; Walter Taylor; Piero Olliaro; Karen I Barnes
Journal:  Eur J Clin Pharmacol       Date:  2008-04-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.